Howard Hughes Medical Institute’s SLB Ltd SLB Stock Holding History

Howard Hughes Medical Institute’s Portfolio SLB Stock Details SLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-322	Closed	-$12.4K	–	405
2025 Q4	$12.4K	Buy	322 +2	+0.6%	+$73	0.01%	179
2025 Q3	$11K	Buy	320 +18	+6%	+$626	0.01%	200
2025 Q2	$10.2K	Buy	+302	New	+$10.5K	﹤0.01%	201
2022 Q4	–	Sell	-405,000	Closed	-$14.5M	–	38
2022 Q3	$14.5M	Buy	+405,000	New	+$14.7M	4.13%	4
2017 Q4	–	Sell	-30,000	Closed	-$2.09M	–	31
2017 Q3	$2.09M	Hold	30,000	–	–	0.52%	29
2017 Q2	$1.98M	Hold	30,000	–	–	0.36%	53
2017 Q1	$2.34M	Hold	30,000	–	–	0.43%	50
2016 Q4	$2.52M	Hold	30,000	–	–	0.58%	44
2016 Q3	$2.36M	Hold	30,000	–	–	0.61%	47
2016 Q2	$2.37M	Buy	+30,000	New	+$2.3M	0.8%	44
2015 Q1	–	Sell	-70,000	Closed	-$5.98M	–	191
2014 Q4	$5.98M	Hold	70,000	–	–	1.6%	17
2014 Q3	$7.12M	Hold	70,000	–	–	1.58%	11
2014 Q2	$8.26M	Sell	70,000 -363	-0.5%	-$37.4K	1.39%	7
2014 Q1	$6.86M	Buy	70,363 +363	+0.5%	+$32.8K	0.97%	14
2013 Q4	$6.31M	Hold	70,000	–	–	0.95%	23
2013 Q3	$6.18M	Hold	70,000	–	–	0.95%	16
2013 Q2	$5.02M	Buy	+70,000	New	+$5.18M	1.65%	29

Other funds holding SLB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Howard Hughes Medical Institute's SLB Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of SLB Ltd (SLB) in Q1 2026, closing a stake of 322 shares — an estimated $12.4K sold.

Howard Hughes Medical Institute first reported a position in SLB in Q2 2013 and held it in 17 quarters. The position peaked at $14.5M in Q3 2022. 1,683 funds tracked by Wall St. Rank hold SLB as of Q1 2026.

Howard Hughes Medical Institute reported no remaining SLB Ltd position as of Q1 2026 after selling out during the quarter.
Howard Hughes Medical Institute sold 322 SLB Ltd shares in Q1 2026, an estimated $12.4K.
Howard Hughes Medical Institute first reported a position in SLB Ltd in Q2 2013 and held it in 17 quarters.
Howard Hughes Medical Institute's SLB Ltd position peaked at $14.5M in Q3 2022.
1,683 funds tracked by Wall St. Rank held SLB Ltd as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.